show episodes
 
In the Decade of Biotech when there will be myriad opportunities to invest in angel-scale biotech startups. After decades of angel investing, I am focusing on the life science side of my portfolio and invite other angels to do the same. Here's why: https://www.labcoatventures.com/why-we-are-focused-on-early-stage-biotech/ I’m Sal Daher, host of the Angel Invest Boston Podcast. After immigrating to Boston as a child and attending Belmont High School, I studied engineering at MIT and Stanford. ...
 
Loading …
show series
 
Angel-scale biotech: Learn More While at Harvard Medical School, Senan Ebrahim was deeply affected by witnessing a still birth. Convinced better data could have avoided the tragedy, he founded Delfina Care with Priyanka Vaidya from EMOTIV, the EEG platform, and his brother Ali Ebrahim, PhD, a former Tech Lead at Google. Senan and Priyanka joined me…
 
Angels helping biotech startups: Learn More Exited founder Sean Kevlahan, PhD tells the story of Quad Technologies and how an interesting polymer contributed to the explosion of cell therapies in the last decade. Sean gives great advice for biotech founders and investors, and joins Armon Sharei in my pantheon of chemical engineers who are gifted co…
 
Opportunities in Angel-Scale Biotech: Learn More Founder Justin Real tells us how Realplay Sports survived the COVID pause and set itself up to serve booming customer demand in 2022 and 2023. In the 2-year hiatus, Realplay expanded the type customers it can address and brought in partners to enrich its product offering. An inspiring chat with a com…
 
The promise of angel-scale biotech: Learn More Founder & VC Aaron Michel of 1984.vc on portfolio companies, Reggora, Faimarkit and Relevize and how they exemplify the firm’s approach to seed-stage investing. Aaron also gives Sal a mind-expanding suggestion on angel-scale biotech. Compelling & jargon-free! Sponsored by Purdue University entrepreneur…
 
Why angel-scale biotech is so promising: Learn More Qiuyan Xu, PhD is a statistician, an entrepreneur and a colleague at Walnut. We talked about the startups she has invested in, her immigrant journey and the work she does at Gravitate AI (https://www.gravitate.ai) Sponsors: Purdue University entrepreneurship & Peter Fasse, patent attorney at Fish …
 
Angel-scale biotech is hot: Learn More Slater Victoroff founded Indico Data in his dorm room at Olin in 2012. Two years later Indico had gone through Techstars and was VC-backed. Hear the story of how making deep learning accessible to enterprise customers led to massive growth. Sponsored by Purdue University entrepreneurship and Peter Fasse, paten…
 
Angel-scale biotech is exploding: Learn More Practicing urologist and founder Jeremy Wiygul, MD believes millions of people are suffering needlessly due to the inadequate delivery of effective treatment, among these his own wife. Pelex aims to use new technology to integrate existing resources and greatly enhance patient outcomes for people with pe…
 
Erik Bullen, founder, angel and listener, gives us an overview of his startups and how his life has changed since exiting his last company. Highlights: Sal Daher Introduces Erik Bullen, Angel, Founder & Listener Erik Bullen Is Excited About Focal Point, a SaaS Solution in the Procurement Space “It's one of those stories where he could not find a so…
 
Angel-scale biotech is taking off: Learn More Susan Conover of Piction Health, is building an AI to improve results and reduce costs in the treatment of skin conditions. Piction has amassed 500,000 diagnosed images and is already helping primary care physicians interpret skin problems in patients. A great chat with an inspiring founder. Highlights:…
 
Angel-scale biotech is hot! Learn More Psychiatrist and founder Jacqueline Olds on her startup and her mission to fight loneliness in America. Words of wisdom and lots of laughs in this interview that could actually make your life better. Brought to you by: Purdue University entrpreneurship, and Peter Fasse, patent attorney at Fish & Richardson Hig…
 
The Promise of Angel-Scale Biotech: Learn More The miracle-working CEO of portfolio company Finetune Learning is back to tell us about the latest developments in applying artificial intelligence in educational assessments. We also got into remote work and explored how to support younger workers in creating professional networks while working remote…
 
The Promise of Angel-Scale Biotech: Learn More SPVs (Special Purpose Vehicles) are democratizing startup investing. In this interview with Jeremy Neilson, founder of Assure.co, we discussed how founders and angels can benefit from these increasingly economical platforms and what they mean for the future. Highlights: Sal Daher Introduces Jeremy Neil…
 
The Opportunitites in Angel-Scale Biotech: https://syndicate.angelinvestboston.com/en-us/the-surge-of-opportunities-in-angel-scale-biotech The dynamic duo of founder Adam Martel and super angel Christopher Mirabile are back on the podcast to report on the sale of Gravyty and to discuss Adam’s new startup, Givzey. Highlights: Gravyty Created a New C…
 
Why Sal Is Bullish on Biotech: Click Here Adam de Sola Pool, a highly successful pioneer in green tech investing in the 1990s, now sees huge opportunities in blue tech. Don’t miss this fascinating tour of ocean technologies conducted by an engaging investor/guide. Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at F…
 
Why Sal Is Bullish on Biotech VeraMorph has a new way to deliver insoluble drugs by mouth. Founder Doug Godfrin, PhD elucidates the promise of accessing the 85% of drugs that are not soluble. Does VeraMorph pass Sal Daher’s screen for angel-scale biotech? Listen and find out. Sponsors: Purdue University entrepreneurship and Peter Fasse, patent atto…
 
Click to Learn About Opportunities in Angel-Scale Biotech Diane Stokes, founder and angel investor, is back to update us on her startups. This inspiring triathlete has great ideas for startups who want to scale. Highlights: Sal Daher Welcomes Back Iron Woman Diane Stokes, Founder & Angel This Interview Picks Up Where the Prior Interview Left Off – …
 
Join Sal's Syndicate: https://syndicate.angelinvestboston.com/en-us/the-surge-of-opportunities-in-angel-scale-biotech Artificial intelligence guru Gil Syswerda is back to talk about angel investing and to give practical advice to founders. We closed with entertaining stories from Gil’s career. Highlights: AI Guru Gil Syswerda Is Back to with Tips f…
 
Why Sal's Bullish on Angel-Scale Biotech: Learn More Sponsored by Purdue University entrepreneurship and peter Fasse, patent attorney at Fish & Richardson Founder Matt Breen of Rahoo Baby is back to update us on the progress of the company and on their new product, Walk Block. This startup is building a brand around helping parents support the cogn…
 
When Semyon Dukach’s family came to America as refugees from the Soviet Union, they had a hundred dollars to their name. Semyon is now one of Boston’s most consequential VCs. Along the way he founded a couple of startups himself and made some remarkable angel investments that put him in a position to be helping founders with money and time. He has …
 
Join Sal's Investment Syndicate: Click to Join Listener Robert Nagle is a mathy software guy and an angel investor. We had a great chat which included his perceptions of the risks in biotech investing and also discussed some of the companies in his portfolio. This is an instructive conversation with a thoughtful angel investor. Sponsored by: Purdue…
 
When Sid Satish saw his first surgery he was struck by the contrast between the advanced technologies in use side by side with ancient practices such as the negotiation over how much patient blood has been lost. He saw an opportunity to apply technology to create an informed calculation of blood loss. This was in 2011, now this technology runs on i…
 
Join Sal's Investment Syndicate: Click to Join Salvatore Viscomi, MD founded his own startup and is now with GoodCell which isolates and stores cells of healthy patients who may need them for future cell therapies. The startup is founded by David Scadden, MD of the Harvard Stem Cell Institute. A truly informative interview. Sponsored by Purdue Univ…
 
Sal's Syndicate: Click to Join Virtual visits & robotics to improve greatly the recovery of stroke patients. Chrissy Glover & her startup, Imago Rehab, are taking to market technology from Harvard's Biodesign Lab informed by deep experience in how stroke rehabilitation is done now. Highlights: Sal Daher Introduces Chrissy Glover, Co-Founder of Imag…
 
Sal's Investment Syndicate: Click to Join Harvard’s Tom Eisenmann is the author of Why Startups Fail: A New Roadmap for Entrepreneurial Success. We discussed valuable lessons from the book and how they might apply to biotech startups. Highlights: Sal Daher Introduces Prof. Tom Eisenmann of the Harvard Business School, Author of Why Startups Fail Ho…
 
Join Sal's Syndicate: Click to Join Genius founder Sam Bogoch of Axle.ai returns to the podcast to tells us the secrets of equity crowdfunding. Axle.ai helps enterprises with massive video files make them usable. The startup has found great success on Republic and Sam has wisdom to share. Highlights: Sal Daher Introduces Sam Bogoch Founder of Axle.…
 
Loading …

Quick Reference Guide

Copyright 2022 | Sitemap | Privacy Policy | Terms of Service
Google login Twitter login Classic login